ID

29220

Description

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00614120

Link

https://clinicaltrials.gov/show/NCT00614120

Keywords

Versions (1)
  1. 3/8/18 3/8/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 8, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT00614120

English

Eligibility Diabetes NCT00614120

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
Description

Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C1265611
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
Description

Glucohemoglobin measurement | Antidiabetics Oral Alone

Data type

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0205171
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
Description

Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0009429
bmi less than 45.0 kg/m^2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with insulin within the last 3 months prior to the trial
Description

Insulin regime

Data type

boolean

Alias
UMLS CUI [1]
C0557978
impaired liver or/and renal function
Description

Liver Dysfunction | Renal Insufficiency

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
significant cardiovascular disease over the last 6 months
Description

Cardiovascular Disease Disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0872146
known retinopathy or maculopathy
Description

Retinal Disease | Disorder of macula of retina

Data type

boolean

Alias
UMLS CUI [1]
C0035309
UMLS CUI [2]
C0730362
recurrent major hypoglycaemia or hypoglycaemic unawareness
Description

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Data type

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
Back to the top of the page

Similar models

Eligibility Diabetes NCT00614120

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity
Item
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
boolean
C0011860 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral Alone
Item
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy
Item
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0009429 (UMLS CUI [3])
Body mass index
Item
bmi less than 45.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin regime
Item
treatment with insulin within the last 3 months prior to the trial
boolean
C0557978 (UMLS CUI [1])
Liver Dysfunction | Renal Insufficiency
Item
impaired liver or/and renal function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Cardiovascular Disease Disease length
Item
significant cardiovascular disease over the last 6 months
boolean
C0007222 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Retinal Disease | Disorder of macula of retina
Item
known retinopathy or maculopathy
boolean
C0035309 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial